Fujian Wanchen Biotechnology Co. Ltd Cash Flow Quality Index
Fujian Wanchen Biotechnology Co. Ltd cash flow quality index. Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow Quality Index of 2.70x as of December 2025. Operating cash flow of CN¥3.63 Billion exceeds net income of CN¥1.34 Billion, indicating high earnings quality where cash backs reported profits. See Fujian Wanchen Biotechnology Co. Ltd (300972) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Cash flow quality index of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. Historical Cash Flow Quality Index for Fujian Wanchen Biotechnology Co. Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Fujian Wanchen Biotechnology Co. Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Fujian Wanchen Biotechnology Co. Ltd Cash Flow Quality Index by Year (2019–2025)
Fujian Wanchen Biotechnology Co. Ltd cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Fujian Wanchen Biotechnology Co. Ltd. For the full cash flow conversion analysis, see 300972 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.70x | CN¥3.63 Billion | CN¥1.34 Billion | ▼ -6.6% |
| 2024 | 2.89x | CN¥848.35 Million | CN¥293.52 Million | ▲ +96.1% |
| 2022 | 1.47x | CN¥70.38 Million | CN¥47.77 Million | ▼ -63.8% |
| 2021 | 4.07x | CN¥98.82 Million | CN¥24.28 Million | ▲ +150.4% |
| 2020 | 1.63x | CN¥156.24 Million | CN¥96.13 Million | ▼ -15.5% |
| 2019 | 1.92x | CN¥177.28 Million | CN¥92.19 Million | — |